Calidi Biotherapeutics, Inc.
Leading the fight against cancer with targeted stem cell and viral therapies that activate the immune system to destroy solid tumors and metastatic disease.
Funding history
About Calidi Biotherapeutics, Inc.
How much funding has Calidi Biotherapeutics, Inc. raised?
Calidi Biotherapeutics, Inc. has raised $10.3M in total funding. The most recent round was Series B.
Where is Calidi Biotherapeutics, Inc. headquartered?
Calidi Biotherapeutics, Inc. is headquartered in San Diego, CA.
What does Calidi Biotherapeutics, Inc. do?
Leading the fight against cancer with targeted stem cell and viral therapies that activate the immune system to destroy solid tumors and metastatic disease.
What's Calidi Biotherapeutics, Inc.'s solution?
Calidi describes itself as engineering genetic medicines that are precisely delivered to sites of disease, spanning cancer and other complex diseases.
What makes Calidi Biotherapeutics, Inc. notable?
Calidi Biotherapeutics is a publicly traded company, listing on the NYSE American exchange under the ticker CLDI despite still being a clinical-stage immuno-oncology company.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.